Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Clinical trial NCT06406634 · RECRUITING
Trial details
- NCT number
- NCT06406634
- Sponsor
- Hunan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2026-04-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.